Poso A - Search Results

1

Development of a 3D model for the human cannabinoid CB1 receptor.

Salo OM, Lahtela-Kakkonen M, Gynther J, Järvinen T, Poso A. Salo OM, et al. Among authors: poso a. J Med Chem. 2004 Jun 3;47(12):3048-57. doi: 10.1021/jm031052c. J Med Chem. 2004. PMID: 15163186

2

An empirical and theoretical study on mechanisms of mutagenic activity of hydrazine compounds.

Poso A, von Wright A, Gynther J. Poso A, et al. Mutat Res. 1995 Nov;332(1-2):63-71. doi: 10.1016/0027-5107(95)00155-2. Mutat Res. 1995. PMID: 7500993

3

Changes in solid-state structure of cyclophosphamide monohydrate induced by mechanical treatment and storage.

Ketolainen J, Poso A, Viitasaari V, Gynther J, Pirttimäki J, Laine E, Paronen P. Ketolainen J, et al. Among authors: poso a. Pharm Res. 1995 Feb;12(2):299-304. doi: 10.1023/a:1016251614844. Pharm Res. 1995. PMID: 7784349

4

Competitive inhibition of coumarin 7-hydroxylation by pilocarpine and its interaction with mouse CYP 2A5 and human CYP 2A6.

Kinonen T, Pasanen M, Gynther J, Poso A, Järvinen T, Alhava E, Juvonen RO. Kinonen T, et al. Among authors: poso a. Br J Pharmacol. 1995 Nov;116(6):2625-30. doi: 10.1111/j.1476-5381.1995.tb17217.x. Br J Pharmacol. 1995. PMID: 8590980 Free PMC article.

5

A rhodopsin-based model for melatonin recognition at its G protein-coupled receptor.

Navajas C, Kokkola T, Poso A, Honka N, Gynther J, Laitinen JT. Navajas C, et al. Among authors: poso a. Eur J Pharmacol. 1996 May 23;304(1-3):173-83. doi: 10.1016/0014-2999(96)00114-8. Eur J Pharmacol. 1996. PMID: 8813600

6

Pronounced differences in inhibition potency of lactone and non-lactone compounds for mouse and human coumarin 7-hydroxylases (CYP2A5 and CYP2A6).

Juvonen RO, Gynther J, Pasanen M, Alhava E, Poso A. Juvonen RO, et al. Among authors: poso a. Xenobiotica. 2000 Jan;30(1):81-92. doi: 10.1080/004982500237848. Xenobiotica. 2000. PMID: 10659953

7

Deformation behaviors of tolbutamide, hydroxypropyl-beta-cyclodextrin, and their dispersions.

Suihko E, Poso A, Korhonen O, Gynther J, Ketolainen J, Paronen P. Suihko E, et al. Among authors: poso a. Pharm Res. 2000 Aug;17(8):942-8. doi: 10.1023/a:1007523103979. Pharm Res. 2000. PMID: 11028939

8

A comparative molecular field analysis of cytochrome P450 2A5 and 2A6 inhibitors.

Poso A, Gynther J, Juvonen R. Poso A, et al. J Comput Aided Mol Des. 2001 Mar;15(3):195-202. doi: 10.1023/a:1008102217770. J Comput Aided Mol Des. 2001. PMID: 11289074

9

Substrate-dependent, non-hyperbolic kinetics of pig brain prolyl oligopeptidase and its tight binding inhibition by JTP-4819.

Venäläinen JI, Juvonen RO, Forsberg MM, Garcia-Horsman A, Poso A, Wallen EA, Gynther J, Männistö PT. Venäläinen JI, et al. Among authors: poso a. Biochem Pharmacol. 2002 Aug 1;64(3):463-71. doi: 10.1016/s0006-2952(02)01184-x. Biochem Pharmacol. 2002. PMID: 12147298

10

Molecular determinants of steroid inhibition for the mouse constitutive androstane receptor.

Jyrkkärinne J, Mäkinen J, Gynther J, Savolainen H, Poso A, Honkakoski P. Jyrkkärinne J, et al. Among authors: poso a. J Med Chem. 2003 Oct 23;46(22):4687-95. doi: 10.1021/jm030861t. J Med Chem. 2003. PMID: 14561088

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

303 results

Search Page

Filters